Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine Read more
Gavi to award $75 million to Serum Institute of India for introduction of the pneumonia vaccine in developing countries Read more
Govt nod for manufacture of COVID-19 vaccine before clinical trials end will expedite access: Industry Read more